🖼
Fig. 2 — Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatmen
active
paper figure
Created: 2026-04-21T18:29:40
By: paper_figures_tool
Quality:
50%
🔗 External
ID: paper-fig-paper-36332796-3
Fig. 2Figure 3
Neuromodulatory effects of gut-derived microbial products. The GM releases several products that play pivotal roles in regulating the immune system, ENS, CNS, and integrity of the intestinal and blood–brain barrier. Molecules such as short-chain fatty acids (SCFAs), mucin-degrading enzymes, and hydrogen sulfide, through their effects on respective organ systems produce anti-inflammatory and neuroprotective effects. Lipopolysaccharide (LPS) on the other hand is proinflammatory and exacerbates oxidative stress and inflammation, which results in neurodegeneration.
▸Metadata
| pmid | paper-36332796 |
| caption | Neuromodulatory effects of gut-derived microbial products. The GM releases several products that play pivotal roles in regulating the immune system, ENS, CNS, and integrity of the intestinal and bloo |
| image_url | https://www.ebi.ac.uk/europepmc/articles/PMC10403695/bin/gr2.jpg |
| paper_title | Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment. |
| figure_label | Fig. 2 |
| figure_number | 3 |
| _schema_version | 1 |
| source_strategy | pmc_api |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.